CRISPR Therapeutics AG (CRSP)
52.80
+1.08
(+2.09%)
USD |
NASDAQ |
Sep 14, 15:11
CRISPR Therapeutics 1 Year Total Returns (Daily) : -7.46% for Sept. 11, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 11, 2026 | -7.46% |
| September 10, 2026 | 0.87% |
| September 09, 2026 | -0.45% |
| September 08, 2026 | 1.26% |
| September 04, 2026 | 5.78% |
| September 03, 2026 | 6.63% |
| September 02, 2026 | 8.09% |
| September 01, 2026 | 9.63% |
| August 31, 2026 | 9.94% |
| August 28, 2026 | 8.80% |
| August 27, 2026 | 10.91% |
| August 26, 2026 | 7.93% |
| August 25, 2026 | 12.51% |
| August 24, 2026 | 5.07% |
| August 21, 2026 | 12.65% |
| August 20, 2026 | 9.52% |
| August 19, 2026 | 10.43% |
| August 18, 2026 | -8.02% |
| August 17, 2026 | -9.12% |
| August 14, 2026 | -8.96% |
| August 13, 2026 | -5.83% |
| August 12, 2026 | -4.61% |
| August 11, 2026 | -2.42% |
| August 10, 2026 | -2.71% |
| August 07, 2026 | -4.36% |
| Date | Value |
|---|---|
| August 06, 2026 | -8.34% |
| August 05, 2026 | -5.65% |
| August 04, 2026 | -10.94% |
| August 03, 2026 | -11.62% |
| July 31, 2026 | -14.70% |
| July 30, 2026 | -16.02% |
| July 29, 2026 | -19.28% |
| July 28, 2026 | -25.41% |
| July 27, 2026 | -27.84% |
| July 24, 2026 | -29.55% |
| July 23, 2026 | -30.25% |
| July 22, 2026 | -28.35% |
| July 21, 2026 | -26.30% |
| July 20, 2026 | -27.85% |
| July 17, 2026 | -13.27% |
| July 16, 2026 | -11.92% |
| July 15, 2026 | -2.58% |
| July 14, 2026 | -10.56% |
| July 13, 2026 | -10.86% |
| July 10, 2026 | -9.58% |
| July 09, 2026 | -6.22% |
| July 08, 2026 | 7.99% |
| July 07, 2026 | 18.71% |
| July 06, 2026 | 18.63% |
| July 02, 2026 | 16.28% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Vertex Pharmaceuticals, Inc. | 29.71% |
| Basilea Pharmaceutica AG | 14.24% |
| Santhera Pharmaceuticals Holding AG | 7.55% |
| BeOne Medicines Ltd. | 3.23% |
| AC Immune SA | 15.97% |